Market capitalization of Galectin Therapeutics (GALT)

Market cap: NZ$0.27 Billion

As of October 2024 Galectin Therapeutics has a market cap of NZ$0.27 Billion. This makes Galectin Therapeutics the world's 8225th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 16th, 2024 the market cap of Galectin Therapeutics was reported to be:

NZ$0.27 Billion

by Yahoo Finance

NZ$0.27 Billion

by CompaniesMarketCap

NZ$0.27 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Mirati Therapeutics MRTX	NZ$6.79 B	2,413.97%	🇺🇸 USA
MannKind Corp MNKD	NZ$3.05 B	1,029.92%	🇺🇸 USA